Company

Corporate Leadership

Dr. Gregory Piefer

Chief Executive Officer

Dr. Piefer is the founder of SHINE Medical Technologies and presently serves as its CEO. Before this, he served as the president of Phoenix Nuclear Labs, where he managed the development of high-output particle sources. He formerly served as the Chief Technical Officer to Gillware Inc., a leading data recovery and backup company. He holds a PhD in nuclear engineering, and BS degrees in physics and electrical and computer engineering from the University of Wisconsin–Madison. He is excited to work on commercialization of revolutionary scientific developments that now offer the opportunity to serve humanity.

Todd Asmuth

President

Mr. Asmuth has been a SHINE Board Member for 2 years and has 15 years of experience managing early-stage companies. At SHINE, he is responsible for investor and customer relations. Early in his career, he spent 4 years in management consulting with Booz Allen Hamilton on strategy engagements with Fortune 500 companies. Most recently Mr. Asmuth served as CEO of AquaMost, a water purification company that commercialized a UW Madison technology. Immediately prior to AquaMost, he was the President of Surebond, a specialty chemical manufacturer with a line of environmentally friendly adhesives and sealants. In addition, he sits on the board of directors of multiple early-stage companies and non-profit organizations. Mr. Asmuth earned an MBA with honors from the Kellogg School of Management at Northwestern University and a B.S. in Mechanical Engineering from Yale University.

Darin Janecek

Chief Financial Officer

Mr. Janecek has over 20 years of experience in corporate finance, M&A, and consulting, in both public and private companies of various sizes. Before joining SHINE, Mr. Janecek served as CFO for ARI Network Services, where he was a member of an executive team that grew the company more than 40% and achieved records levels of profitability and cash flow, significantly enhancing shareholder value. During his tenure at ARI, Mr. Janecek was instrumental in the execution of three strategic acquisitions, multiple debt financings, a private equity placement, and the company’s listing on the Nasdaq exchange. Prior to ARI, Mr. Janecek was the Strategic Finance Director for Johnson Controls. In addition, he provided consulting services to private equity firms as a member of the Transaction Advisory Services practices at FTI Consulting and Crowe Horwath, was Director of Mergers & Acquisitions at CNA Insurance, and served in various corporate accounting and finance roles for middle market companies in health care and manufacturing. He began his career as an auditor at Deloitte & Touche. He earned his MBA at Loyola University and his undergraduate degree in accounting at the University of Wisconsin – Milwaukee.

Katrina Pitas

Vice President, Business Development

Ms. Pitas is Vice President, Business Development of SHINE. Before joining SHINE in 2011, Ms. Pitas did research and development work for Phoenix Nuclear Labs.  In her capacity as VP of Business Development, she has played a key leadership role in implementing SHINE’s strategic vision and driving SHINE’s growth and development.  Ms. Pitas was a key player in securing early funding for SHINE, and has also made important contributions to SHINE’s regulatory efforts.  Ms. Pitas’ background is in Physics, and before joining Phoenix Nuclear Labs, she gained experience living in both China and Japan.

Jim Costedio

Vice President Regulatory Affairs and Quality

Mr. Costedio has over 30 years of nuclear experience in Licensing, Engineering, and Training. Before joining SHINE, he was responsible for developing strategies and the direction and oversight of licensing activities at the Point Beach Nuclear Power Plant. During his tenure at Point Beach he provided oversight of the license renewal program implementation and the 17% Extended Power Uprate. His experience includes managing the licensing department at the James A. FitzPatrick nuclear plant. While at FitzPatrick, he served in a supervisory capacity in the engineering and training departments. He earned a B.S. in Applied Science & Technology from Thomas Edison State College in New Jersey and a B.S. in Human Resources Management from the New School for Social Research in New York.

George Hansrote

Vice President Project Delivery

Mr. Hansrote has over 30 years of experience in project management, having spent the first half of his career working on nuclear power plant projects, and the second half working on first-of-a-kind nuclear facilities. Prior to joining SHINE, he served most recently as the Executive Director, Nuclear Dismantling & Decommissioning for CB&I, Power Division, and has also successfully managed large-scale projects at Sellafield in the UK, Urenco’s National Enrichment Facility, Los Alamos National Laboratory, and Hanford, among many others. He has substantial experience in engineering, purchasing, contracts, project controls, and construction. His previous project scopes of responsibility ranged from $100 million to $3+ billion, with limits of authority as high as $10 million. Mr. Hansrote holds B.S. degrees in both Mechanical Engineering with an Aerospace Option and Biology with a Chemistry Minor, as well as an A.S. in Architecture.

Eric Van Abel

Vice President Engineering

Mr. Van Abel is Vice President, Engineering of SHINE and has been with SHINE since 2011. He leads the overall engineering effort for SHINE’s construction of the medical isotope facility in Janesville, WI. Before his current role, Mr. Van Abel served as the design lead for the subcritical fission systems that generate the medical isotopes, then managed the design of the irradiation facility and associated systems, and then subsequently served as the engineering design manager for the entire project, including irradiation and chemical processing of isotopes. Before joining SHINE, Mr. Van Abel worked in nuclear reactor safety for Dominion Energy at the Kewaunee nuclear power plant and helped to ensure safe and reliable nuclear power plant operation. Mr. Van Abel holds M.S. and B.S. degrees in nuclear engineering from UW-Madison, where he graduated with highest distinction.

Board of Directors

Dr. Thomas “Rock” Mackie

Dr. Mackie currently serves as Director of Medical Devices at the Morgridge Institute for Research and as a professor in the departments of Medical Physics, Human Oncology, and Engineering Physics at the University of Wisconsin–Madison. He is the author of more than 130 peer-reviewed publications, 25 patents, and has supervised more than 25 PhD students. With his expertise in radiation therapy treatment planning and intensity-modulated radiotherapy, his group developed the PinnacleTM treatment planning system, now marketed by Philips Medical. He is a co-founder and Chairman of the Board of TomoTherapy, Inc., a Madison-based company employing 650 people. Dr. Mackie received his B.S. in Physics from the University of Saskatchewan in 1980 and his doctorate in Physics from the University of Alberta in 1984.

Dr. Gregory Piefer

Dr. Piefer is the founder of SHINE Medical Technologies and presently serves as its CEO. Before this, he served as the president of Phoenix Nuclear Labs, where he managed the development of high-output particle sources. He formerly served as the Chief Technical Officer to Gillware Inc., a leading data recovery and backup company. He holds a PhD in nuclear engineering, and BS degrees in physics and electrical and computer engineering from the University of Wisconsin–Madison. He is excited to work on commercialization of revolutionary scientific developments that now offer the opportunity to serve humanity.

Richard Leazer

Richard Leazer was Managing Director of the Wisconsin Alumni Research Foundation prior to his retirement in 2000. He was President of Ohmeda, a medical device and equipment manufacturer, and a division of BOC, from 1988 through 1992. From 1981 to 1988 he was President of Anaquest, a specialty pharmaceutical company and a division of BOC. Mr. Leazer was a founding co-manager of a Madison-based angel investing network, Wisconsin Investment Partners, LLC. Former positions also include President of the WIN Foundation, which sponsors the Wisconsin Venture Fair as well as a Technology luncheon series, and founding President of the Wisconsin Technology Council, an organization working to improve Wisconsin’s high technology company environment. He is a past or active Director of several healthcare products companies and was a Trustee of the Weinert Applied Ventures Program for Entrepreneurship at the UW-Madison School of Business. Mr. Leazer received a bachelor’s degree in Business Administration from the University of Iowa in 1963 and an MBA from the Drexel Institute of Technology in 1966.

Donald J. Whelley

Donald J. Whelley is the Managing Member of DJW Advisors, providing advisory services to institutional and high net worth clients. Don has worked for over thirty years in energy and financial services providing valuation and advisory services and most recently supporting clients investing in other industry sectors including mining and biotech. After graduating with a BS in Accounting from Clarkson University, Don began his professional career working as an auditor for Arthur Andersen. Don’s career has included accounting, finance and acquisition work for companies involved in oil and gas, agricultural biotech, broker dealer and syndication of real estate investments and energy consulting. Currently, Don serves as a Director of GeoResources Inc. (Houston TX) a publicly traded exploration & production company, Director of SHINE Medical Technologies, Inc. (Middleton, WI) a private producer of medical isotopes, Board Observer of Dynamis Therapeutics, Inc. (Philadelphia, PA) a private biotech, Board Observer of Flugen, Inc. (Madison, WI) a private medical device maker/vaccine company, and Advisory Board member of Blue Ocean Consulting, Inc. (Lawrence, KS) an internet software and consulting firm.

Philip M. Halpern

Philip M. Halpern is the managing partner of the law firm of Collier, Halpern, Newberg, Nolletti & Bock, LLP, with offices in New York City, White Plains and Stamford, Connecticut.  Mr. Halpern is a magna cum laude graduate of Fordham University, where he majored in economics, and is a graduate of Pace University School of Law where he obtained his juris doctor.  Mr. Halpern is a Fellow of the American Bar Foundation and member of the Office of Court Administration’s Advisory Committee on Civil Practice.  Mr. Halpern has been a member of the Advisory Council for the Board of Judges for the Southern District of New York.  Mr. Halpern is a member of the Association of the Bar of the City of New York, the Committee on Federal Judiciary for the New York State Bar Association, the American Bar Association, the New York County Lawyers Association, New York State Trial Lawyers Association, the Association of Trial Lawyers of America, and the Federal Bar Council.  Mr. Halpern began his legal career in 1980 as a law clerk to a federal judge in the Southern District of New York.

Todd Asmuth

Todd Asmuth joined SHINE as its President in September 2015 after spending 5 years as CEO of AquaMost, Inc. He has spent 20 years building early stage companies as an operator and investor. Immediately prior to AquaMost, he was the President of Surebond, a specialty chemical manufacturer with a line of environmentally friendly adhesives and sealants. He has a history of successfully taking companies from concept to commercialization to profitability using lean startup, customer-focused product development techniques. In addition, he sits on the board of directors of multiple early stage companies and non-profit organizations. Early in his career, Todd spent 4 years in management consulting with Booz Allen & Hamilton on strategy engagements with Fortune 500 companies. Todd earned an MBA with honors from the Kellogg School of Management at Northwestern University and a B.S. in Mechanical Engineering from Yale University. He is a member of the Society of Petroleum Engineers.

Gregory OD Smith

Gregory OD Smith joins the SHINE board with 39 years of leadership experience in the nuclear industry and a track record of creating effective partnerships. Gregory has served as the Chairman of Urenco UK and Urenco’s Chief Culture Officer. Prior to that, he served as Chairman of the Board and Chief Executive Officer for Louisiana Energy Services (LES), a uranium enrichment company wholly owned by Urenco. As CEO of LES, he oversaw the completion of construction and startup of the National Enrichment Facility in New Mexico. Before joining LES, Mr. Smith worked for Ontario Power Generation. During 2002‑2006, he served as the Senior Vice President for the 4-unit Darlington Nuclear station. From 1992-2002, he worked at Energy Northwest where he held several positions, including Operations Division Manager, Plant General Manager, Vice President Nuclear Operations, and Vice President Generation.

 

Advisers

Dr. Paul M. DeLuca

Dr. DeLuca received his B.S. in physics and math in 1966 and a doctorate in nuclear physics from the University of Notre Dame in 1971. That same year he joined the University of Wisconsin–Madison, and has since served as a professor in the departments of Medical Physics, Radiology, Human Oncology, Engineering Physics and Physics. He now serves as Provost and Vice Chancellor for Academic Affairs. Dr. DeLuca’s research interests have concentrated on fast neutron dosimetry including production of intense sources of fast neutrons, determination of elemental neutron kerma factors and application of microdosimetry to radiation dosimetry. He is currently vice chairman of the International Commission on Radiation Units and Measurements at Los Alamos.

Dr. Harrison Schmitt

Dr. Harrison Schmitt has a diverse professional background having served as a geologist, pilot, astronaut, businessman, writer and United States Senator. Selected for the Scientist-Astronaut Program in 1965. He served as a Mission Scientist in support of the Apollo 11 mission. After training as back-up Lunar Module pilot for Apollo 15, Dr. Schmitt flew in space as Lunar Module pilot for Apollo 17 – the last Apollo mission to the Moon. He was the only scientist and the last of twelve men to step onto the Moon. He served in the U.S. Senate, continues to work in science, aerospace and business, and chaired the NASA Advisory Council from 2005-2008. Schmitt serves as Adjunct Professor of Engineering at the University of Wisconsin–Madison. In addition to being active in considerations of space biomedical adaptation, he has worked in the biomedical field as Acting CEO for the Lovelace Medical Foundation and currently as a Director of PHDx Systems, a software developer and supplier for medical device outcomes. Schmitt is the author of “Return to the Moon” (Copernicus-Praxis 2006), a book advocating a private sector initiative to develop lunar helium-3 fusion power for use on Earth.

James L. Connaughton

Mr. Connaughton is Executive Vice President with C3 Energy, which offers big data energy analytics solutions to utilities and to oil and gas companies. Prior to joining C3 Energy, Mr. Connaughton served as Executive Vice President and Senior Policy Advisor of Exelon Corporation, and Executive Vice President, Corporate Affairs, Public and Environmental Policy for Constellation Energy. From 2001 to 2009, Mr. Connaughton was Chairman of the White House Council on Environmental Quality. In this capacity, he served on President Bush’s staff as senior environment, energy and natural resources advisor and as director of the White House Office of Environmental Policy. He holds a bachelor’s degree from Yale University and a J.D. from Northwestern University School of Law.

Scott Klug

Mr. Klug is the Managing Director of Public Affairs at the national law firm of Foley & Lardner LLP. He chairs the firm’s Client Service Team. For eight years, Mr. Klug represented Madison, Wisconsin in the U.S. Congress, where he developed an expertise in health care, energy policy and financial services. He was appointed by President Bush to two terms to the Advisory Committee to the United States Trade Representative. Prior to his election to Congress, he was an Emmy award-winning reporter/anchor in Washington, D.C., Seattle and his native Wisconsin. A novelist, his freelance writing has appeared in a number of U.S. newspapers and magazines. Before he joined Foley, he founded a regional magazine and book publishing company which he sold in 2007. Mr. Klug holds an M.B.A. in finance from the University of Wisconsin, a Master’s in journalism from Northwestern and a B.A. from Lawrence University.

Christopher Manuele

Mr. Manuele is a results-oriented, innovative executive with thirty five years of comprehensive US and International expertise in nuclear medicine and medical isotope production. A long-time veteran of Amersham Health and GE Healthcare, he has launched core products; expanded products internationally; led the design, construction and FDA-approval of two brand new U.S. manufacturing facilities; and held responsibility for several full-GMP radiopharmaceutical manufacturing sites across the US and Europe. Before his retirement in 2008, Mr. Manuele served as General Manager – Global Nuclear Medicine Supply Chain for GE Healthcare, and General Manager – Oncura, GE’s global I-125 brachytherapy seeds business. He has an impeccable track record of operational excellence, continuous profitability improvement, and implementation of industry-leading quality systems.

Martyn Coombs

Mr. Coombs is a recognized leader in the nuclear medicine industry. Most recently, as President of Jubilant DraxImage, he led the company through a period of rapid organic growth, tripling revenue in four years. He built a strong team, advanced the development pipeline toward approval, and built the company’s strategy toward becoming the industry leader. Mr. Coombs has also spent nine years with Amersham/GE Healthcare, including five years in Japan as the Executive Vice President of Nihon Medi-Physics. He holds a degree in Mathematics and an MBA with distinction from Warwick Business School. In 2017, he was appointed as the new CEO of ImaginAb.